Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms

B Majumder, NB Nataraj, L Maitreyi… - Frontiers in Immunology, 2024 - frontiersin.org
Mismatch repair proficient (MMRp) tumors of colorectal origin are one of the prevalent yet
unpredictable clinical challenges. Despite earnest efforts, optimal treatment modalities have …

Patient-derived organoids in precision cancer medicine

L Tong, W Cui, B Zhang, P Fonseca, Q Zhao, P Zhang… - Med, 2024 - cell.com
Organoids are three-dimensional (3D) cultures, normally derived from stem cells, that
replicate the complex structure and function of human tissues. They offer a physiologically …

Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy

M Logun, X Wang, Y Sun, SJ Bagley, N Li, A Desai… - Cell Stem Cell, 2024 - cell.com
Patient-derived tumor organoids have been leveraged for disease modeling and preclinical
studies but rarely applied in real time to aid with interpretation of patient treatment responses …

A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells

P Fonseca, W Cui, N Struyf, L Tong… - Journal of Experimental …, 2024 - Springer
Background Tumor cells have the ability to invade and form small clusters that protrude into
adjacent tissues, a phenomenon that is frequently observed at the periphery of a tumor as it …

ExoDS: a versatile exosome-based drug delivery platform to target cancer cells and cancer stem cells

S Paul, S Bhagat, L Dash, HD Mohapatra… - … in Bioengineering and …, 2024 - frontiersin.org
Chemotherapy drugs like doxorubicin (Dox) are widely used in middle-income countries
around the world to treat various types of cancers, including breast cancer. Although they …

Drug response-based precision therapeutic selection for tamoxifen-resistant triple-positive breast cancer

VS Bisht, D Kumar, MA Najar, K Giri, J Kaur… - Journal of …, 2025 - Elsevier
Breast cancer adaptability to the drug environment reduces the chemotherapeutic response
and facilitates acquired drug resistance. Cancer-specific therapeutics can be more effective …

[PDF][PDF] CARM1 在恶性肿瘤中的作用与机制研究进展

刘树义, 马泽方, 肖洒雨, 高璐, 曹明琪, 陈子溦… - 生命科学 …, 2024 - smkx.hunnu.edu.cn
共激活蛋白相关的精氨酸甲基转移酶1 (coactivator-associated arginine methyltransferase 1,
CARM1) 是蛋白质精氨酸甲基转移酶(protein arginine methyltransferase, PRMT) 家族的成员 …

[HTML][HTML] Patient-derived response estimates from zero-passage organoids of luminal breast cancer

RK Przanowska, N Labban, P Przanowski, RB Hawes… - bioRxiv, 2024 - ncbi.nlm.nih.gov
Background Primary luminal breast cancer cells lose their identity rapidly in standard tissue
culture, which is problematic for testing hormone interventions and molecular pathways …

Personalised Medicine: Establishing predictive machine learning models for drug responses in patient derived cell culture

A Abdel-Rehim, O Orhobor, G Griffiths… - arXiv preprint arXiv …, 2024 - arxiv.org
The concept of personalised medicine in cancer therapy is becoming increasingly important.
There already exist drugs administered specifically for patients with tumours presenting well …

Zebrafish Avatar-test predicts patient's tumor response to chemotherapy in breast cancer: a co-clinical study towards personalized medicine

RV Mendes, J Ribeiro, H Gouveia, CR Almeida… - bioRxiv, 2024 - biorxiv.org
Chemotherapy remains the mainstay in most high-risk breast cancer (BC) settings, with
several equivalent options of treatment. However, the efficacy of each treatment varies …